Traditional Chinese Medicine Combined With Chemotherapy and Cetuximab or Bevacizumab for Metastatic Colorectal Cancer: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Traditional Chinese Medicine Combined With Chemotherapy and Cetuximab or Bevacizumab for Metastatic Colorectal Cancer: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

BackgroundHuangci Granule is a traditional Chinese medicine for treating metastatic colorectal cancer (mCRC).ObjectiveTo evaluate the efficacy and safety of Huangci Granule combination with chemotherapy and cetuximab (CET) or bevacizumab (BV) for treating mCRC.MethodsWe performed a randomized, contr...

Full description

Bibliographic Details
Main Authors: Ningning Liu, Chaojun Wu, Ru Jia, Guoxiang Cai, Yan Wang, Lihong Zhou, Qing Ji, Hua Sui, Puhua Zeng, Haijuan Xiao, Huaimin Liu, Jiege Huo, Yuanyuan Feng, Wanli Deng, Qi Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-04-01
Series:Frontiers in Pharmacology
Subjects:
traditional Chinese medicine
metastatic colorectal cancer
cetuximab (CET) or bevacizumab (BV)
progression-free survival
quality of life
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2020.00478/full

Internet

https://www.frontiersin.org/article/10.3389/fphar.2020.00478/full

Similar Items